Surgical Intervention in Patients with Penile Neoplasm at a University Hospital before and after the COVID-19 Pandemic

Author(s): Plínio José Esteves Correia, Maria Victória Figueiredo Rebolho, Lilian Castiglioni, Luis Cesar Fava Spessoto, Fernando Nestor Facio Junior

Objective: Penile cancer (PC) is a rare disease associated with a lack of hygiene, phimosis, low sociocultural level and the human papillomavirus. In urology, its treatment is part of oncological surgeries that cannot be postponed for a given period of time without affecting patient’s survival. Considering this, the aim of this study is to investigate surgical interventions in patients with PC at a university hospital before and after a period characterized by a tendency to postpone elective surgeries, the COVID-19 pandemic. Methods: This retrospective study was performed with penile cancer patients at the urology clinic of a university hospital. Data were collected from the electronic records of patients sent for hospital treatment. Descriptive statistics were conducted to compare surgical or not surgical interventions before and after the pandemic. Results: A total of 32 patients were analyzed, 18 and 14 were diagnosed prior and after the COVID-19 pandemic, respectively. Comparisons of the frequency of surgeries realized before and after revealed to have a nonsignificant difference (p = 0.4651). When the patients were stratified by age group, significant difference was found regarding the number of surgeries performed previously the pandemic (p = 0.0366) – a finding that was not confirmed following its onset (p = 0.3508). Conclusion: At the university hospital analyzed, COVID-19 pandemic did not have a significant impact on the frequency of surgeries for PC. Either, after its beginning, age no longer exerted an influence on the treatment decision.

Penile Neoplasm, Penile Cancer, COVID-19

1. Compérat E. Pathology of penile cancer. Eur Urol Suppl. 2018;17:132–137. https://doi.org/10.1016/j.eursup.2017.08.005
2. Câncer de pênis. Instituto Nacional de Câncer/Ministério da Saúde, 2021. Disponível em: < https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/penis>. Accessed August, 2023.
3. Attalla K, Paulucci DJ, Blum K, et al. Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: a report from the national cancer database. Urol Oncol. 2018;36:14 e17–14 e24. https://doi.org/10.1016/j.urolonc.2017.09.014.
4. Facio FN Jr, Warick Facio MF, Nagle Spessoto AC, Godoy M, Tessaro H, Campos R, Zanatto D, Calmon M, Rahal P, Fava Spessoto LC. Clinical and Molecular Profile of Patients With Condyloma Acuminatum Treated in the Brazilian Public Healthcare System. Cureus. 2022 Feb 6;14(2):e21961. doi: 10.7759/cureus.21961.
5. Andrew B. Katims, Shirin Razdan, Benjamin M. Eilender, Peter Wiklund, Ashutosh K. Tewari, Natasha Kyprianou, Ketan K. Badani, and Reza Mehrazin. Urologic oncology practice during CO- VID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable. Urol Oncol. 2020 Oct; 38(10): 783–792. Published online 2020 Jun 26. doi: 10.1016/j.urolonc.2020.06.028.
6. Nelson Canales Casco 1, María Jiménez Carmona 1, Álvaro Juárez Soto. Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era. Int Braz J Urol. 2020 Jul;46(suppl.1):86-92. http://orcid.org/0000-0002-5458-7615.
7. Isamu Tachibana, Ethan L. Ferguson, Ashorne Mahenthiran, Jay P. Natarajan, Timothy A. Master- son, Clinton D. Bahler, and Chandru P. Sundaram. Delaying Cancer Cases in Urology during COVID- 19: Review of the Literature. Journal of Urology Review Articles1 Nov 2020. https://doi.org/10.1097/ju.0000000000001288.
8. Wallis, Christopher J. D., et al. “Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic”. European Urology, vol. 78, no 1, July 2020, p. 29–42. PubMed Central, https://doi.org/10.1016/j.eururo.2020.04.063.
9. Izadmehr, Sudeh, et al. “The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic”. Frontiers in Oncology, vol. 11, September 2021, p. 734963. PubMed Central, https://doi.org/10.3389/fonc.2021.734963.
10. Zhan, Xiangpeng, et al. “Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population‐based study”. Cancer Medicine, vol. 11, no 11, March 2022, p. 2308–19. PubMed Central, https://doi.org/10.1002/cam4.4614.
11. Cakir, Omer Onur, et al. “Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study”. Urologic Oncology, vol. 39, no 3, March 2021, p. 197.e9-197.e17. PubMed Central, https://doi.org/10.1016/j.urolonc.2020.12.005.
12. Stensland, Kristian D., et al. “Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic”. European Urology, vol. 77, no 6, June 2020, p. 663–66. PubMed Central, https://doi.org/10.1016/j.eururo.2020.03.027.
13. Ian Janes, W. C., et al. “A quality assurance review of penile cancer diagnostic delays and stage at presentation during the COVID-19 pandemic”. Canadian Urological Association Journal, vol. 17, no 5, May 2023, p. E134–40. PubMed Central, https://doi.org/10.5489/cuaj.8143.
14. Bandini, Marco, et al. “A global approach to improving penile cancer care”. Nature Reviews. Urology, vol. 19, no 4, 2022, p. 231–39. PubMed Central, https://doi.org/10.1038/s41585-021-00557-y.
15. Fu, Leiwen, et al. “Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study”. JMIR Public Health and Surveillance, vol. 8, no 7, July 2022, p. e34874. PubMed Central, https://doi.org/10.2196/34874.